<ul><li>A recent study published in JAMA assessed a novel blood test for colorectal cancer screening in average-risk populations.</li><li>The test analyzed circulating tumor DNA and other biomarkers to detect molecular changes indicating colorectal cancer.</li><li>Results showed the test had good accuracy for detecting colorectal cancer but faced challenges in identifying advanced precancerous lesions.</li><li>Technological advancements in liquid biopsy science offer opportunities for personalized screening and early cancer intervention.</li></ul>

Clinical Validation of a Blood Test Using Circulating Tumor DNA for Colorectal Cancer Screening

Discover more